Home
Conditions
Lymphatic Diseases

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

8,990 public trials 1,836 recruiting studies

Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Not Yet Recruiting

A Resilience-Based Approach to Improve Long-term Quality of Life in Post-treatment Lymphoma Survivorship

NCT07013435

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations: Mass General Hospital Boston, Massachusetts, United States

View Trial Details

Not Yet Recruiting

A Study of Inotuzumab and Blinatumomab in People With B-cell Acute Lymphoblastic Leukemia

NCT07313852

Conditions: B-ALL, B-Cell Acute Lymphoblastic Leukemia, Adult, B-cell Acute Lymphoblastic Leukemia, +17 more
Locations: Memorial Sloan Kettering Cancer Center (All Protocol Activities) New York, United States

View Trial Details

Not Yet Recruiting

A Clinical Trial to Evaluate the Efficacy and Safety of TQB3909 Tablets Versus Investigator's Choice in the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

NCT07753369

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +15 more
Locations: Henan Province Zhengzhou, Henan, China

Jiangsu Provincial People's Hospital Nanjing, Jiangsu, China

View Trial Details

Not Yet Recruiting

Genetically Engineered Cells (BAFFR-CAR T Cells) for the Treatment of Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia and B-cell Lymphoblastic Lymphoma

NCT07758673

Conditions: Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +23 more
Locations: City of Hope Medical Center Duarte, California, United States

City of Hope at Irvine Lennar Irvine, California, United States

View Trial Details

Not Yet Recruiting

Immunoglobulin Replacement Therapy (IgRT) Versus Antibiotic Prophylaxis (PA) in Patients Treated by CD19-targeted Chimeric Antigen Receptor (CAR)T Cells for a B Cell Acute Lymphoblastic Leukemia or a B Cell Lymphoma

NCT07754682

Conditions: Antibiotic Prophylaxis, B Cell Acute Lymphoblastic Leukemia (B-ALL), B Cell Lymphoma, +19 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Plasma ctDNA Monitoring in Pediatric Acute Leukemia

NCT07751588

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Hematologic Diseases, +12 more
Locations: Department of Pediatric Hematology/Oncology,Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China

View Trial Details

Not Yet Recruiting

Study of ALA-101 in Patients With CD19 Positive Non-Hodgkin Lymphoma and Leukemia.

NCT07518329

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: Royal Adelaide Hospital Adelaide, South Australia, Australia

The Alfred Hospital Melbourne, Victoria, Australia

Epworth HealthCare Richmond, Victoria, Australia

St. Vincent's Hospital Sydney, New South Wales, Australia

View Trial Details

Not Yet Recruiting

Digital Patient-Reported Assessment in Older Adults With Acute Leukemia

NCT07597590

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: Hospital Universitario Central de Asturias (HUCA) Oviedo, Principality of Asturias, Spain

View Trial Details

Not Yet Recruiting

A Study Comparing a New Drug (Surovatamig) With Standard Radiotherapy With or Without Rituximab in Adults With Limited Stage Nodal Follicular Lymphoma

NCT07736950

Conditions: Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Pirtobrutinib+Sonrotoclax（PS) Regimen in the Treatment of B-Cell Lymphoma

NCT07744750

Conditions: CLL / SLL, DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, +8 more
Locations: Jiangsu Province Hospital The First Affiliated Hospital with Nanjing Medical University Nanjing, Jiangsu, China

View Trial Details

Lymphatic Diseases

Lymphatic Diseases trial results

Related conditions